The researchers who developed the vaccine say it could be the strategy that finally helps millions of smokers quit, reports Health24. Lead investigator Dr Ronald Crystal said that, while they have only tested mice to date, they are "very hopeful that this kind of vaccine strategy can finally help the millions of smokers who have tried to stop, exhausting all the methods on the market today but finding their nicotine addiction to be strong enough to overcome these current approaches."
According to Health24, however, previously tested vaccines that delivered nicotine antibodies directly failed in clinical trials because they lasted only a few weeks and had inconsistent results.
Read the full article on www.health24.com
